C

Canntab Therapeutics Ltd
CNSX:PILL

Watchlist Manager
Canntab Therapeutics Ltd
CNSX:PILL
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: 194.6k CAD

Net Margin
Canntab Therapeutics Ltd

-4 565.3%
Current
-1 384%
Average
3.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4 565.3%
=
Net Income
-3.4m
/
Revenue
73.5k

Net Margin Across Competitors

No Stocks Found

Canntab Therapeutics Ltd
Glance View

Market Cap
194.5k CAD
Industry
N/A

Canntab Therapeutics Ltd. is a biopharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2011-04-21. The firm is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm operates in one reportable operating, being engaged in the medical marijuana business. All property and equipment, right-of-use assets and intangible assets are located in Canada. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. The company holds cannabis standard processing and sales for medical purposes license, a cannabis research license, and an industrial hemp license from health Canada.

PILL Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4 565.3%
=
Net Income
-3.4m
/
Revenue
73.5k
What is the Net Margin of Canntab Therapeutics Ltd?

Based on Canntab Therapeutics Ltd's most recent financial statements, the company has Net Margin of -4 565.3%.

Back to Top